Sofinnova Investments, Inc. - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 111 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.

Quarter-by-quarter ownership
Sofinnova Investments, Inc. ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$4,596,672
-28.7%
631,411
-20.8%
0.27%
-27.2%
Q3 2022$6,450,000
+18.8%
797,262
+247.4%
0.38%
-9.0%
Q1 2022$5,428,000
-50.3%
229,509
-62.8%
0.41%
-35.4%
Q4 2021$10,927,000
+659.3%
617,670
+1111.0%
0.64%
+650.6%
Q3 2021$1,439,00051,0060.08%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TRV GP IV, LLC 2,343,154$10,403,6043.92%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,718,881$25,391,8321.37%
COWEN AND COMPANY, LLC 4,308,359$19,129,1131.34%
RA Capital Management 11,609,704$51,547,0861.02%
RTW INVESTMENTS, LP 5,818,804$25,835,4900.54%
Acuitas Investments, LLC 134,811$598,5610.35%
Simplify Asset Management Inc. 570,519$2,533,1040.29%
Vivo Capital, LLC 520,000$2,308,8000.25%
BRANDYWINE MANAGERS, LLC 26,127$116,0040.20%
DENALI ADVISORS LLC 70,600$313,4640.11%
View complete list of FULCRUM THERAPEUTICS INC shareholders